Course Provider
Learning Objectives
Describe normal and impaired pulmonary defenses and causes of impaired secretion mobilization in acute and chronic illness patients.
Recognize the role of secretion retention leading to pulmonary complications (PC) in hospitalized and chronic illness patients.
Appreciate the therapeutic role of HFCWO across the continuum of care over the past quarter century.
Discuss HFCWO mechanisms of action that promote secretion mobilization and clinical/laboratory research supporting safety and efficacy.
Understand strategies for identifying patients at risk for secretion-related PC who may benefit from post-discharge HFCWO therapy.
Appreciate how broadly applied interventions may reduce hospitalizations / readmissions and improve patient outcomes.